GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Wuhan Easy Diagnosis Biomedicine Co Ltd (SZSE:002932) » Definitions » E10

Wuhan Easy Diagnosis Biomedicine Co (SZSE:002932) E10 : ¥3.84 (As of Sep. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Wuhan Easy Diagnosis Biomedicine Co E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Wuhan Easy Diagnosis Biomedicine Co's adjusted earnings per share data for the three months ended in Sep. 2024 was ¥0.070. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ¥3.84 for the trailing ten years ended in Sep. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2025-03-28), Wuhan Easy Diagnosis Biomedicine Co's current stock price is ¥18.63. Wuhan Easy Diagnosis Biomedicine Co's E10 for the quarter that ended in Sep. 2024 was ¥3.84. Wuhan Easy Diagnosis Biomedicine Co's Shiller PE Ratio of today is 4.85.

During the past 13 years, the highest Shiller PE Ratio of Wuhan Easy Diagnosis Biomedicine Co was 5.14. The lowest was 4.57. And the median was 4.89.


Wuhan Easy Diagnosis Biomedicine Co E10 Historical Data

The historical data trend for Wuhan Easy Diagnosis Biomedicine Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wuhan Easy Diagnosis Biomedicine Co E10 Chart

Wuhan Easy Diagnosis Biomedicine Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Wuhan Easy Diagnosis Biomedicine Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 3.84

Competitive Comparison of Wuhan Easy Diagnosis Biomedicine Co's E10

For the Medical Devices subindustry, Wuhan Easy Diagnosis Biomedicine Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Wuhan Easy Diagnosis Biomedicine Co's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Wuhan Easy Diagnosis Biomedicine Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Wuhan Easy Diagnosis Biomedicine Co's Shiller PE Ratio falls into.


;
;

Wuhan Easy Diagnosis Biomedicine Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Wuhan Easy Diagnosis Biomedicine Co's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=0.07/115.7848*115.7848
=0.070

Current CPI (Sep. 2024) = 115.7848.

Wuhan Easy Diagnosis Biomedicine Co Quarterly Data

per share eps CPI Adj_EPS
201112 0.000 92.885 0.000
201212 0.000 95.237 0.000
201306 1.450 95.984 1.749
201312 1.200 97.624 1.423
201406 1.480 98.200 1.745
201412 -1.010 99.000 -1.181
201506 0.390 99.500 0.454
201512 0.340 100.600 0.391
201606 0.000 101.400 0.000
201612 0.000 102.600 0.000
201706 0.680 103.100 0.764
201709 0.080 104.100 0.089
201712 0.122 104.500 0.135
201803 0.087 105.300 0.096
201806 0.164 104.900 0.181
201809 0.048 106.600 0.052
201812 0.061 106.500 0.066
201903 0.077 107.700 0.083
201906 0.116 107.700 0.125
201909 0.023 109.800 0.024
201912 -0.016 111.200 -0.017
202003 0.010 112.300 0.010
202006 0.958 110.400 1.005
202009 0.753 111.700 0.781
202012 0.527 111.500 0.547
202103 1.595 112.662 1.639
202106 1.110 111.769 1.150
202109 2.034 112.215 2.099
202112 1.866 113.108 1.910
202203 6.047 114.335 6.124
202206 5.873 114.558 5.936
202209 4.660 115.339 4.678
202212 1.630 115.116 1.639
202303 0.480 115.116 0.483
202306 0.160 114.558 0.162
202309 0.140 115.339 0.141
202312 -0.300 114.781 -0.303
202403 0.140 115.227 0.141
202406 0.140 114.781 0.141
202409 0.070 115.785 0.070

Add all the adjusted EPS together and divide 10 will get our e10.


Wuhan Easy Diagnosis Biomedicine Co  (SZSE:002932) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Wuhan Easy Diagnosis Biomedicine Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=18.63/3.84
=4.85

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Wuhan Easy Diagnosis Biomedicine Co was 5.14. The lowest was 4.57. And the median was 4.89.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Wuhan Easy Diagnosis Biomedicine Co E10 Related Terms

Thank you for viewing the detailed overview of Wuhan Easy Diagnosis Biomedicine Co's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Wuhan Easy Diagnosis Biomedicine Co Business Description

Traded in Other Exchanges
N/A
Address
No. 1 Dongxin Road, 2 Floor, Building E, International Students Pioneer Park, Guandong Science and Technology Park, Donghu Development Zone, Hubei, Wuhan, CHN, 430075
Wuhan Easy Diagnosis Biomedicine Co Ltd is engaged in the research and development, production and sales of in vitro diagnostic reagents and supporting instruments and mobile ECG products. The company's product profile consists of Molecular diagnosis, Chemiluminescence, Blood gas analysis, and others. It also provides various other solutions such as Mingde Biomolecular Diagnostic Service Solution, Mingde Biothoracic Center Solution, POCT Solution, Remote ECG network construction solution, and others.
Executives
Wang Jian Fei Director
Wang Rui Directors, executives

Wuhan Easy Diagnosis Biomedicine Co Headlines

No Headlines